DK585889D0 - PHARMACEUTICAL PREPARATION - Google Patents
PHARMACEUTICAL PREPARATIONInfo
- Publication number
- DK585889D0 DK585889D0 DK585889A DK585889A DK585889D0 DK 585889 D0 DK585889 D0 DK 585889D0 DK 585889 A DK585889 A DK 585889A DK 585889 A DK585889 A DK 585889A DK 585889 D0 DK585889 D0 DK 585889D0
- Authority
- DK
- Denmark
- Prior art keywords
- polyoxyethylene glycol
- component
- carboxylic acid
- pharmaceutical preparation
- ester
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Pharmaceutical product containing (a) a compound with antibacterial activity, and (b) an effective amount of an absorption-promoting 2-component system which contains as first component (b 1) an ether composed of a C6-C18-alcohol and polyoxyethylene glycol and as second component either (b 2-1) a polyoxyethylene glycol C6-C18-carboxylic acid glyceride ester, or (b 2-2) a C6-C18-carboxylic acid or a pharmaceutically utilisable salt thereof, or (b 2-3) an ester composed of two or more C6-C18-carboxylic acids, glycerol and a polyoxyethylene glycol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27459088A | 1988-11-22 | 1988-11-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK585889D0 true DK585889D0 (en) | 1989-11-21 |
DK585889A DK585889A (en) | 1990-05-23 |
Family
ID=23048828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK585889A DK585889A (en) | 1988-11-22 | 1989-11-21 | PHARMACEUTICAL PREPARATION |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0370481B1 (en) |
JP (1) | JPH0774165B2 (en) |
KR (1) | KR900007412A (en) |
AT (1) | ATE94765T1 (en) |
AU (1) | AU625276B2 (en) |
CA (1) | CA2003340A1 (en) |
DE (1) | DE58905681D1 (en) |
DK (1) | DK585889A (en) |
HU (1) | HU205713B (en) |
IE (1) | IE63119B1 (en) |
IL (1) | IL92357A (en) |
NZ (1) | NZ231447A (en) |
PH (1) | PH26390A (en) |
YU (1) | YU221889A (en) |
ZA (1) | ZA898331B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4115849A1 (en) * | 1991-05-15 | 1992-11-19 | Lohmann Therapie Syst Lts | PENETRATION PROMOTING SUBSTANCE |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
SI9400338A (en) * | 1994-08-31 | 1996-04-30 | Lek D D | Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules. |
IT1275802B1 (en) * | 1994-11-03 | 1997-10-17 | Hoffmann La Roche | INTERFERONE COMPOSITION |
FR2775188B1 (en) * | 1998-02-23 | 2001-03-09 | Lipha | IMMEDIATE RELEASE ORAL EXTENDED RELEASE GALENIC FORM COMPRISING AN ABSORPTION PROMOTING AGENT AND USE OF THE ABSORPTION PROMOTING AGENT |
IL125244A (en) * | 1998-07-07 | 2002-12-01 | Yissum Res Dev Co | Pharmaceutical compositions containing low-melting waxes |
EP1154761B1 (en) * | 1999-02-22 | 2008-02-20 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
JP4489356B2 (en) | 2001-05-11 | 2010-06-23 | メリオン リサーチ スリー リミテッド | Penetration enhancer |
MX2008012678A (en) | 2006-04-07 | 2008-12-17 | Merrion Res Iii Ltd | Solid oral dosage form containing an enhancer. |
KR20110007242A (en) | 2008-05-07 | 2011-01-21 | 메리온 리서치 Ⅲ 리미티드 | Compositions of peptides and processes of preparation thereof |
NZ591810A (en) | 2008-09-17 | 2012-12-21 | Chiasma Inc | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid |
US9089484B2 (en) | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
CN103476419A (en) | 2011-01-07 | 2013-12-25 | 梅里翁第三研究有限公司 | Pharmaceutical compositions of iron for oral administration |
ES2975708T3 (en) | 2015-01-29 | 2024-07-12 | Novo Nordisk As | Tablets comprising GLP-1 agonist and enteric coating |
US10238709B2 (en) | 2015-02-03 | 2019-03-26 | Chiasma, Inc. | Method of treating diseases |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1168949A (en) * | 1979-08-13 | 1984-06-12 | William G. Gorman | Cleansing compositions |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
JPS59212427A (en) * | 1983-05-19 | 1984-12-01 | Kyoto Yakuhin Kogyo Kk | Composition for rectum administration |
EP0126348A2 (en) * | 1983-05-19 | 1984-11-28 | Kyoto Pharmaceutical Industries, Ltd. | Composition for rectal administration and method of promoting rectal drug absorption |
CA1256799A (en) * | 1984-02-22 | 1989-07-04 | Walter Fuller | Suppositories |
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
-
1989
- 1989-11-01 ZA ZA898331A patent/ZA898331B/en unknown
- 1989-11-20 CA CA002003340A patent/CA2003340A1/en not_active Abandoned
- 1989-11-20 NZ NZ231447A patent/NZ231447A/en unknown
- 1989-11-20 IL IL9235789A patent/IL92357A/en not_active IP Right Cessation
- 1989-11-21 JP JP1300926A patent/JPH0774165B2/en not_active Expired - Lifetime
- 1989-11-21 DK DK585889A patent/DK585889A/en not_active Application Discontinuation
- 1989-11-21 IE IE371889A patent/IE63119B1/en not_active IP Right Cessation
- 1989-11-21 EP EP89121548A patent/EP0370481B1/en not_active Expired - Lifetime
- 1989-11-21 PH PH39561A patent/PH26390A/en unknown
- 1989-11-21 KR KR1019890016872A patent/KR900007412A/en not_active Application Discontinuation
- 1989-11-21 AT AT89121548T patent/ATE94765T1/en not_active IP Right Cessation
- 1989-11-21 AU AU45384/89A patent/AU625276B2/en not_active Ceased
- 1989-11-21 DE DE89121548T patent/DE58905681D1/en not_active Expired - Fee Related
- 1989-11-22 HU HU896123A patent/HU205713B/en not_active IP Right Cessation
- 1989-11-22 YU YU02218/89A patent/YU221889A/en unknown
Also Published As
Publication number | Publication date |
---|---|
YU221889A (en) | 1992-05-28 |
EP0370481A2 (en) | 1990-05-30 |
NZ231447A (en) | 1992-09-25 |
IL92357A (en) | 1994-10-07 |
IE63119B1 (en) | 1995-03-22 |
EP0370481B1 (en) | 1993-09-22 |
IE893718L (en) | 1990-05-22 |
DE58905681D1 (en) | 1993-10-28 |
HU205713B (en) | 1992-06-29 |
DK585889A (en) | 1990-05-23 |
JPH0774165B2 (en) | 1995-08-09 |
HU896123D0 (en) | 1990-02-28 |
EP0370481A3 (en) | 1991-01-16 |
ZA898331B (en) | 1990-07-25 |
KR900007412A (en) | 1990-06-01 |
HUT52374A (en) | 1990-07-28 |
PH26390A (en) | 1992-07-02 |
AU4538489A (en) | 1990-05-31 |
AU625276B2 (en) | 1992-07-09 |
ATE94765T1 (en) | 1993-10-15 |
IL92357A0 (en) | 1990-07-26 |
CA2003340A1 (en) | 1990-05-22 |
JPH02180837A (en) | 1990-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK585889A (en) | PHARMACEUTICAL PREPARATION | |
DE3669882D1 (en) | 2-CYANACRYLIC ACID ESTER COMPOSITION. | |
NO863061L (en) | PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PHENOXYDICOIC ACID DERIVATIVES. | |
DK581185D0 (en) | PHARMACEUTICAL PREPARATION CONTAINING 13-CIS-A-VITAMIC ACID | |
DE3868037D1 (en) | PHARMACEUTICAL COMPOSITION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE. | |
NO862734L (en) | PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID ESTERS. | |
DE3884517D1 (en) | BIOLOGICALLY ACTIVE CARBON ACID ESTERS. | |
MY100647A (en) | Pharmaceuticals formulations. | |
DE3778132D1 (en) | 2-BETA-SUBSTITUTED METHYLPENICILLANIC ACID DERIVATIVES AND THEIR SALTS AND ESTERS. | |
KR920701213A (en) | Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient | |
DE3674351D1 (en) | Optically active benzoic acid ester derivatives. | |
IL65922A0 (en) | Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them | |
IT8267345A0 (en) | COMPOUND AND PHARMACEUTICAL COMPOSITION TO ACCELERATE WOUND HEALING | |
PH21875A (en) | Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient | |
DK99085D0 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING A-VITAMIC ACID DERIVATIVES | |
IT8619288A0 (en) | INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS GENERAL ANESTHETICAL SUITABILITY. | |
NO863005D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES. | |
NL8100209A (en) | METHYLPENAMCARBONIC ACID SULPHONES, SALTS AND THEIR ESTERS, AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
IT8447848A0 (en) | 7-(1-PYRRYL)- AND 7-(1-PYRROLIDINIL)-6-FLUORO-1-ETHYL-1,4-DIHYDRO4-KETOQUINOLIN-3-CARBOXYLIC ACIDS ANTIMICROBIAL ADAPTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOUNDS THAT THEM THEY CONTAIN | |
JPS56128731A (en) | Ester of arylpropionic acid, manufacture and medicine of effective ingredient | |
ATE95164T1 (en) | BIOLOGICALLY ACTIVE CARBONIC ACID ESTERS. | |
NO851195L (en) | PROCEDURE FOR THE PREPARATION OF ASCORBIC ACID ESTERS. | |
IL59304A0 (en) | Pharmaceutical preparation comprising as active ingredient acetyl salicylic acid or salicylic acid | |
ATE71079T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-HALOGENATED DICARBONIC ACIDS. | |
PT87077A (en) | TERC-BUTYLAMINO-3- (PHENYL-2: -PHENOXY) -1-PROPANOL-2 AND ITS ACID ADDITION SALTS FOR USE AS AN ACTIVE THERAPEUTIC SUBSTANCE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |